4//SEC Filing
Mohindru Mani 4
Accession 0001209191-19-059183
CIK 0001346830other
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 7:50 PM ET
Size
7.7 KB
Accession
0001209191-19-059183
Insider Transaction Report
Form 4
Mohindru Mani
CFO & Chief Strategy Officer
Transactions
- Sale
Common Stock
2019-12-04$17.05/sh−4,755$81,073→ 17,441 total - Award
Common Stock
2019-12-02+8,333→ 22,196 total
Footnotes (3)
- [F1]Represents the number of shares that vested under a performance-based restricted stock unit award (the "RSU") based on the Issuer's satisfaction of certain performance criteria of the award. In light of the performance-based vesting conditions of the award, such shares were not reportable under Section 16 until vesting was determined, which occurred on December 2, 2019. The vested shares represents the second of three possible vesting events of the total number of shares subject to the award. The remaining shares subject to the award will vest only upon the satisfaction of additional performance vesting criteria. Each RSU represents the contingent right to receive one share of common stock of the Issuer.
- [F2]This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 on September 6, 2018 to satisfy the tax withholding obligations triggered by the vesting and of the RSUs reported herein as described in greater detail in footnote (1), and does not represent a discretionary trade by the Reporting Person.
- [F3]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding as described in footnote (2).
Documents
Issuer
Cara Therapeutics, Inc.
CIK 0001346830
Entity typeother
Related Parties
1- filerCIK 0001664708
Filing Metadata
- Form type
- 4
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 7:50 PM ET
- Size
- 7.7 KB